FI126047B - Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö - Google Patents

Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö Download PDF

Info

Publication number
FI126047B
FI126047B FI20125888A FI20125888A FI126047B FI 126047 B FI126047 B FI 126047B FI 20125888 A FI20125888 A FI 20125888A FI 20125888 A FI20125888 A FI 20125888A FI 126047 B FI126047 B FI 126047B
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
cells
antiviral
apoptosis
anisomelic acid
Prior art date
Application number
FI20125888A
Other languages
English (en)
Swedish (sv)
Other versions
FI20125888A (fi
Inventor
John Eriksson
Preethy Paul
Emilia Peuhu
M A Akbarsha
Original Assignee
John Eriksson
Preethy Paul
Emilia Peuhu
M A Akbarsha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FI20125888A priority Critical patent/FI126047B/fi
Application filed by John Eriksson, Preethy Paul, Emilia Peuhu, M A Akbarsha filed Critical John Eriksson
Priority to DK13792713.3T priority patent/DK2895162T3/en
Priority to PCT/FI2013/050828 priority patent/WO2014033366A1/en
Priority to US14/423,711 priority patent/US9345687B2/en
Priority to JP2015529085A priority patent/JP2015530381A/ja
Priority to CA2922642A priority patent/CA2922642C/en
Priority to EP13792713.3A priority patent/EP2895162B1/en
Priority to CN201380056583.3A priority patent/CN104869991B/zh
Publication of FI20125888A publication Critical patent/FI20125888A/fi
Priority to US14/827,343 priority patent/US9623002B2/en
Application granted granted Critical
Publication of FI126047B publication Critical patent/FI126047B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20125888A 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö FI126047B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
PCT/FI2013/050828 WO2014033366A1 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
US14/423,711 US9345687B2 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
JP2015529085A JP2015530381A (ja) 2012-08-28 2013-08-28 アニソメル酸の医薬組成物およびその使用
DK13792713.3T DK2895162T3 (en) 2012-08-28 2013-08-28 PHARMACEUTICAL COMPOSITIONS OF ANISOMELY ACID AND ITS APPLICATION
CA2922642A CA2922642C (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
EP13792713.3A EP2895162B1 (en) 2012-08-28 2013-08-28 Pharmaceutical compositions of anisomelic acid and the use thereof
CN201380056583.3A CN104869991B (zh) 2012-08-28 2013-08-28 防风草酸的药物组合物及其应用
US14/827,343 US9623002B2 (en) 2012-08-28 2015-08-17 Pharmaceutical compositions of Anisomelic acid and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö

Publications (2)

Publication Number Publication Date
FI20125888A FI20125888A (fi) 2014-03-01
FI126047B true FI126047B (fi) 2016-06-15

Family

ID=49619952

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20125888A FI126047B (fi) 2012-08-28 2012-08-28 Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö

Country Status (8)

Country Link
US (1) US9345687B2 (fi)
EP (1) EP2895162B1 (fi)
JP (1) JP2015530381A (fi)
CN (1) CN104869991B (fi)
CA (1) CA2922642C (fi)
DK (1) DK2895162T3 (fi)
FI (1) FI126047B (fi)
WO (1) WO2014033366A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623002B2 (en) * 2012-08-28 2017-04-18 John E. Eriksson Pharmaceutical compositions of Anisomelic acid and the use thereof
WO2016027005A1 (en) 2014-08-17 2016-02-25 Åbo Akademi Compounds for the treatment of hpv-induced carcinoma
FI20195527A1 (fi) * 2019-06-17 2020-12-18 Aabo Akademi Ovatodiolidin farmaseuttiset koostumukset ja niiden käytöt
TWI819307B (zh) * 2020-05-19 2023-10-21 吉亞生物科技股份有限公司 萜類化合物在治療或預防纖維化疾病中的用途
EP4185283A4 (en) * 2020-07-23 2024-08-07 Arjil Biotech Holding Company Ltd METHOD AND COMPOSITION FOR INHIBITING VIRUS INFECTIONS
CN112964704B (zh) * 2021-02-04 2024-03-22 甘肃润达药业有限公司 一种防风草内酯检测试纸、比色卡及快速检测方法
WO2022257086A1 (zh) * 2021-06-10 2022-12-15 杨震 一种不对称合成(–)-鱼针草酸的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY120392A (en) * 2000-06-08 2005-10-31 Hovid Berhad A novel drug delivery system : formulation for fat-soluble drugs
US20090291976A1 (en) * 2006-06-27 2009-11-26 Peter Andrew Ferchmin Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
TWI465244B (zh) 2010-12-24 2014-12-21 Ind Tech Res Inst 魚針草萃取物、魚針草內酯及防風草酸在製備預防或治療痛風之醫藥的用途

Also Published As

Publication number Publication date
FI20125888A (fi) 2014-03-01
US9345687B2 (en) 2016-05-24
WO2014033366A1 (en) 2014-03-06
EP2895162A1 (en) 2015-07-22
CA2922642C (en) 2021-02-23
CN104869991B (zh) 2017-12-08
DK2895162T3 (en) 2018-03-26
CA2922642A1 (en) 2014-03-06
JP2015530381A (ja) 2015-10-15
EP2895162B1 (en) 2018-01-03
US20150202180A1 (en) 2015-07-23
CN104869991A (zh) 2015-08-26

Similar Documents

Publication Publication Date Title
EP2895162B1 (en) Pharmaceutical compositions of anisomelic acid and the use thereof
US20210038565A1 (en) Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
WO2017162108A1 (zh) 一种柱芳烃类复合物、其制备方法、药物组合物和用途
WO2009067891A1 (fr) Composés de triterpènephénol solubles dans l'eau ayant une activité anti-tumorale et leur préparation
US8846768B2 (en) Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia
CN115968375A (zh) SARS-CoV-2蛋白与宿主细胞的分子和细胞机制的相互作用以及治疗COVID-19的制剂
US9623002B2 (en) Pharmaceutical compositions of Anisomelic acid and the use thereof
US20130065932A1 (en) Process for the isolation of organic compounds useful for the treatment of cancer
WO2008148269A1 (fr) Médicament anti-tumoral contenant des dérivés d'acide bétulinique
US20220296565A1 (en) Pharmaceutical compositions of Ovatodiolide and the use thereof
JP3507511B2 (ja) アルグラビン（ａｒｇｌａｂｉｎ）およびアルグラビン誘導体の薬学的組成物
US20190083443A1 (en) Ingenol compounds and use thereof in anti-hiv latency treatment
WO2023187791A1 (en) Treatment of viral infections
CN116602961A (zh) 一类rumbrin类化合物在制备抗HIV药物中的用途
KR20070031888A (ko) ３－０－(３＇,３＇-다이메틸숙시닐)베툴린산의 약리학적염
ZA200608624B (en) Pharmaceutical salts of 3-0(3',3'-dimethylsuccinyl) betulinic acid

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 126047

Country of ref document: FI

Kind code of ref document: B

PC Transfer of assignment of patent

Owner name: A BO AKADEMI

PC Transfer of assignment of patent

Owner name: ANISON THERAPEUTICS OY